Filing Details
- Accession Number:
- 0001209191-14-005690
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-29 20:07:35
- Reporting Period:
- 2014-01-27
- Filing Date:
- 2014-01-29
- Accepted Time:
- 2014-01-29 20:07:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
891288 | Questcor Pharmaceuticals Inc | QCOR | Pharmaceutical Preparations (2834) | 330476164 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1326104 | Jeffrey David Medeiros | 1300 North Kellogg Drive Suite D Anaheim CA 92807 | Evp And Cto | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-01-27 | 833 | $35.78 | 118,884 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-01-27 | 833 | $63.73 | 118,051 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2014-01-27 | 833 | $0.00 | 833 | $35.78 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
834 | 2022-02-14 | No | 4 | M | Direct |
Footnotes
- Stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan.
- The option was granted on 02/15/2012 for the right to buy 20,000 shares of common stock of the Issuer. Options vested pursuant to achievement of certain performance-based criteria. As of the date of this report, 834 shares of common stock remain subject to vesting.